Results 181 to 186 of about 6,421 (186)

Nirmatrelvir/ritonavir and pharmacovigilance data

The International Journal of Tuberculosis and Lung Disease
S, Lassan, M, Gocova, I, Solovic, T, Tesar, Z, Motesicka, M, Lassanova   +5 more
openaire   +2 more sources

Nirmatrelvir+ritonavir/tacrolimus

Reactions Weekly
openaire   +2 more sources

Hypermenorrhoea associated with ritonavir

Lancet, The, 1999
exaly  

Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial

Lancet, The, 2012
exaly  

Nifedipine/nirmatrelvir+ritonavir

Reactions Weekly
openaire   +1 more source

Molnupiravir/nirmatrelvir+ritonavir/remdesivir

Reactions Weekly
openaire   +1 more source